학술논문
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.
Document Type
Article
Author
Source
Therapeutic Advances in Medical Oncology; 7/31/2021, p1-17, 17p
Subject
Language
ISSN
17588340
Abstract
Copyright of Therapeutic Advances in Medical Oncology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)